Amundi MSCI Water ESG Screened Fund logo

Amundi MSCI Water ESG Screened Fund (WAT)

Market Closed
5 Dec, 15:30
XMIL XMIL
68. 10
-0.3
-0.44%
- Market Cap
0% Div Yield
2,380 Volume
68.4
Previous Close
Day Range
67.86 68.4
Year Range
58.27 71.94
Want to track WAT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days

Summary

WAT closed today lower at €68.1, a decrease of 0.44% from yesterday's close, completing a monthly decrease of -0.19% or €0.13. Over the past 12 months, WAT stock gained 1.82%.
WAT is not paying dividends to its shareholders.
The last earnings report, released on Nov 04, 2025, exceeded the consensus estimates by 0.18%. On average, the company has fell short of earnings expectations by -1.02%, based on the last three reports. The next scheduled earnings report is due on Feb 11, 2026.
Amundi MSCI Water ESG Screened Fund has completed 2 stock splits, with the recent split occurring on Aug 28, 2000.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on NYSE (USD).

WAT Chart

Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?

Why Is Waters (WAT) Up 6.9% Since Last Earnings Report?

Waters (WAT) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 day ago
Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Waters Corporation (WAT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Waters Corporation ( WAT ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you, everybody.

Seekingalpha | 2 weeks ago
Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y

Waters Q3 Earnings Surpass Estimates, Revenue Increase Y/Y

WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.

Zacks | 4 weeks ago

Amundi MSCI Water ESG Screened Fund (WAT) FAQ

What is the stock price today?

The current price is €68.10.

On which exchange is it traded?

Amundi MSCI Water ESG Screened Fund is listed on NYSE.

What is its stock symbol?

The ticker symbol is WAT.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 4.51.

When is the next earnings date?

The next earnings report will release on Feb 11, 2026.

Has Amundi MSCI Water ESG Screened Fund ever had a stock split?

Amundi MSCI Water ESG Screened Fund had 2 splits and the recent split was on Aug 28, 2000.

Amundi MSCI Water ESG Screened Fund Profile

XMIL Exchange
US Country

Overview

Waters Corporation, established in 1958 and based in Milford, Massachusetts, operates globally, providing advanced analytical workflow solutions across Asia, the Americas, and Europe. The company is structured into two main segments: Waters and TA, through which it offers a broad spectrum of technology systems and support products tailored for scientific research and industrial applications. Waters Corporation's innovation in high and ultra-performance liquid chromatography, mass spectrometry (MS) technology, and assorted support products, including chromatography columns and consumables, is complemented by its service offerings, spanning post-warranty service plans to instrument maintenance. Moreover, the firm's commitment to advancing research and ensuring quality assurance across various sectors is epitomized by its range of thermal analysis, rheometry, and calorimetry instruments, alongside a suite of specialized software products. Serving a diverse clientele, from clinical and pharmaceutical researchers to environmental analysts, Waters Corporation plays a pivotal role in facilitating drug development, environmental testing, and quality assessment of consumer goods, promoting safety and innovation across industries.

Products and Services

  • High and Ultra-Performance Liquid Chromatography (HPLC/UPLC) and Mass Spectrometry (MS) Systems:

    These instruments form the backbone of analytical chemistry, particularly in the separation, identification, and quantification of compounds in samples. Waters Corporation designs, manufactures, and services such systems that are critical for drug discovery and development, clinical trials, protein analysis in disease processes, environmental testing, and nutritional safety analysis.

  • Chromatography Columns and Consumable Products:

    Essential for the effective operation of chromatography systems, these products include a variety of columns and other consumables that ensure precision and reliability in sample analysis across various laboratory applications.

  • Post-Warranty Service Plans:

    Waters Corporation offers comprehensive service plans that extend beyond the warranty, providing maintenance and support for instruments to ensure their optimal performance and longevity.

  • Thermal Analysis, Rheometry, and Calorimetry Instruments:

    The company also specializes in the design and production of instruments used for analyzing the physical properties of materials, such as their response to heat (thermal analysis), flow behavior (rheometry), and energy changes in chemical reactions (calorimetry). These instruments are invaluable in assessing the stability and suitability of materials for industrial, healthcare, and consumer goods applications, as well as for life science research.

  • Software Solutions:

    Developing and supplying advanced software-based products that complement its range of instruments, Waters Corporation ensures seamless integration and enhanced functionality. This software facilitates data analysis and interpretation, contributing to the efficiency and effectiveness of laboratory workflows.

Contact Information

Address: 34 Maple Street
Phone: 508 478 2000